DAVID ALLEN: Open Payments
NPI 1770526709 · HIXSON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,143 in 107 payments from 21 companies in 2025. Trend: 2023 $1,587 · 2024 $1,511 · 2025 $2,143
Food & beverage: $2,143
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 22 | $430 |
| ABBVIE INC. | 13 | $216 |
| Otsuka America Pharmaceutical, Inc. | 9 | $169 |
| PFIZER INC. | 9 | $147 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $126 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $116 |
| Boston Scientific Corporation | 1 | $116 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $115 |
| Lundbeck LLC | 4 | $95 |
| AstraZeneca Pharmaceuticals LP | 6 | $92 |
Products named: REXULTI, Rybelsus, VRAYLAR, Ozempic, Kerendia, XIFAXAN, FARAPULSE, CAPLYTA.
Industry payments across TN — which companies pay providers there.
